Announcement

Collapse
No announcement yet.

Vitamin 'may blunt cancer drugs'

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Vitamin 'may blunt cancer drugs'

    Vitamin C supplements may substantially reduce the benefit from a wide range of anti-cancer drugs, research suggests.

    Thirty to 70% less cancer cells in a lab were killed by a range of drugs, after pretreatment with vitamin C.

    Follow-up chemotherapy tests found tumours grew more rapidly in mice given cancer pretreated with vitamin C.
    Cancer Research reports the Memorial Sloan-Kettering Cancer Center findings. The US researchers say the same mechanism may affect patient outcomes.
    <!-- E SF -->Some studies have suggested that because vitamin C is an antioxidant it could be beneficial to cancer patients.


    The US team tested the impact of a form of vitamin C on the effectiveness of a range of anti-cancer drugs in tests on cancer cells in the lab.

    They found that every drug they tested did not work as well if cells were pretreated with vitamin C as they did on untreated cancer cells.

    Between 30% and 70% less cancer cells treated with vitamin C were killed, depending on the drug tested.
    Follow-up tests on mice showed that while chemotherapy kept untreated cancer in check, tumours grew more rapidly in mice that were given cancer pretreated with vitamin C.

    Some classes of cancer drugs produce molecules known as oxygen free radicals which can react with other molecules in the cancer cell, forcing its death.

    In theory, vitamin C could mop up the free radicals, keeping the cancer cell alive despite chemotherapy treatment.

    Boiler room

    However, the researchers found the key was not that the nutrient was neutralising free radicals.

    Instead, vitamin C appeared to protect tiny structures inside the cancer cells called mitochondria from damage.
    Mitochondria effectively form the energy-creating boiler room of a cell, and if damaged can lead to its death.

    Lead researcher Dr Mark Heaney said: "Vitamin C appears to protect the mitochondria from extensive damage, thus saving the cell.

    "And whether directly or not, all anti-cancer drugs work to disrupt the mitochondria to push cell death."

    Previous research by the same team has shown that vitamin C seems to accumulate within cancer cells more than in normal cells.

    The amount of vitamin C used in the current study were equivalent to that found in high dose supplements.
    Dr Heaney said vitamin C was probably good for cells in normal tissue - but its protective effect was completely counter-productive in relation to cancer cells.

    He added: "The use of vitamin C supplements could have the potential to reduce the ability of patients to respond to therapy."

    Early stage

    Dr Joanna Owens, of the charity Cancer Research UK, said the study was interesting, but at an early stage.
    "As yet, there is not enough evidence to know whether antioxidants such as vitamin C are helpful or harmful during cancer treatment.

    "It is possible that high doses of antioxidants can make treatment less effective, but until we know for sure our advice is to try and get the vitamins you need through a balanced and varied diet rather than through vitamin supplements."

    Pamela Mason, scientific advisor to the Health Supplements Information Service, said no conclusions could be drawn until research was carried out on humans.
    She stressed that cancer patients should seek expert advice before taking any product not prescribed by their doctor.

    BBC, News, BBC News, news online, world, uk, international, foreign, british, online, service
    "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

  • #2
    Re: Vitamin 'may blunt cancer drugs'

    This must be balanced against other articles about the benefits of IV ascorbic acid.

    However, there are some chemotherapy drugs whose mechanism uses free radicals and taking anti-oxidants, beyond normal dietary amounts, can interfere with therapy. Cancer patients should discuss their vitamin C usage with their oncologist.

    .
    "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

    Comment


    • #3
      Re: Vitamin 'may blunt cancer drugs'

      <table border="0" cellpadding="5" cellspacing="0" width="100%"><tbody><tr><td> Au cours d'une chimioth?rapie


      Des doutes sur la suppl?mentation en vitamine C



      L'ASSOCIATION risque d'?tre plut?t d?l?t?re. Selon des ?tudes men?es invitro et chez l'animal, une suppl?mentation en vitamine C pourrait diminuer l'efficacit? d'une chimioth?rapie. Cette notion ?tait d?j? dans l'air, explique le Dr Heaney (Philadelphie). Elle ?tait attribu?e ? l'effet antioxydant de la vitamine sur les chimioth?rapies qui agissent notamment en produisant des radicaux libres.
      Afin de v?rifier cette hypoth?se, l'?quipe am?ricaine a test? diverses chimioth?rapies (productrices ou non de radicaux libres) en les mettant au contact de cellules canc?reuses pr?trait?es, par le d?riv? intracellulaire de la vitamine C, l'acide d?hydroascorbique (DHA). Quelle que soit la chimioth?rapie, de 30 ? 70 % des cellules pr?trait?es ont r?sist? au traitement.
      Un test similaire a ?t? r?alis? sur des souris chez qui des cellules canc?reuses ont ?t? greff?es. Chez les rongeurs pr?trait?s par vitamine C, les tumeurs ont progress? plus rapidement.
      En cherchant ? comprendre les m?canismes impliqu?s, les chercheurs ont ?limin? l'hypoth?se antioxydante, pour se tourner vers les mitochondries. La vitamine C les prot?ge des l?sions dues au processus canc?reux, ce qui pr?vient l'envoi d'un signal d'apoptose par les mitochondries l?s?es. Les cellules tumorales survivent donc.
      Le microenvironnement tumoral, expliquent les auteurs, favorise la transformation de vitamine C dans sa forme absorbable par la cellule, le DHA. Une fois inclus dans la cellule, le DHA se convertit ? nouveau en vitamine C qui, s?questr?e dans la cellule, peut la prot?ger.

      > Dr G. B.

      ? Cancer Research ?, 1er octobre 2008.

      </td> </tr> <tr> <td>Le Quotidien du M?decin du : 01/10/2008





      traduction machine


      With the course of a chemotherapy

      Doubts about the supplementation in vitamin C



      THE ASSOCIATION risks to be rather noxious. According to undertaken studies invitro and at the animal, a supplementation in vitamin C could decrease the effectiveness of a chemotherapy. This concept was already in the air, explains Dr. Heaney (Philadelphia). It was allotted to the antioxydant effect of the vitamin on chemotherapies which act in particular by producing free radicals.
      In order to check this assumption, the American team tested various chemotherapies (producing or not of free radicals) by putting them in contact with pretreated cancer cells, by the intracellular derivative of the vitamin C, the acid dehydroascorbic (DHA). Whatever the chemotherapy, from 30 to 70% of the pretreated cells resisted the treatment.


      A similar test was carried out on mice in which cancer cells were grafted. In the pretreated rodents by vitamin C, the tumours progressed more quickly.


      While seeking to include/understand the implied mechanisms, the researchers eliminated the antioxydant assumption, to turn to the mitochondries. The vitamin C protects them from the lesions due to the cancerous processes, which prevents the sending of a signal of apoptose by the injured mitochondries. The tumoral cells thus survive.



      The microenvironnement tumoral one, explain the authors, supports the transformation of vitamin C in its absorbable form by the cell, the DHA. Once included in the cell, the DHA is converted again into vitamin C which, sequestered in the cell, can protect it.


      </td> </tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0"><tbody><tr> <td style="background-image: url(/img/HP_BX3_TL.png); background-repeat: no-repeat;" width="7" height="7">
      </td> <td style="background-image: url(/img/HP_BX3_CT.png); background-repeat: repeat-x;" height="7">
      </td> <td style="background-image: url(/img/HP_BX3_TR.png); background-repeat: no-repeat;" width="7" height="7">
      </td> </tr> <tr> <td style="background-image: url(/img/HP_BX3_CL.png); background-repeat: repeat-y;">
      </td> <td> <table border="0" cellpadding="5" cellspacing="0" width="100%"> <tbody><tr> <td align="center">
      </td></tr></tbody></table>
      </td></tr></tbody></table>

      Comment


      • #4
        Re: Vitamin 'may blunt cancer drugs'

        Examples of free-radical producing chemo drugs:
        (source - http://www.oncolink.org/treatment/ar...c=2&s=9&id=224 )
        <H3>Anthracyclines

        Many of the currently effective anti-cancer drugs are developed from natural sources. The drug daunorubicin was isolated from Streptomyces, a soil-dwelling fungus. Doxorubicin, another anthracycline drug, was isolated from a mutated strain of the same fungus. Both of these drugs have a similar mechanism of action, but the latter is more effective in the treatment of solid tumors. This class of chemotherapeutics works by the formation of free oxygen radicals. These radicals result in DNA strand breaks and subsequent inhibition of DNA synthesis and function.

        Anthracyclines also inhibit the enzyme topoisomerase by forming a complex with the enzyme and DNA. Topoisomerases are a class of enzymes that serve to unwind the DNA double strand helix to allow for DNA repair, replication and transcription. This class of chemotherapeutics is also not cell cycle specific. The most important side effect of this group of drugs is cardiac toxicity.

        The same free radicals that serve to damage the DNA of the cancer cell may damage the cells of the heart muscle. Oncologists monitor heart function very carefully when patients are on these medications. Other commonly used anthracyclines include Idarubicin, Epirubicin, and Mitoxantrone.
        Antitumor Antibiotics

        Another chemotherapy isolated form the fungus Streptomyces verticullus is Bleomycin. Its mechanism of action is similar to that of the anthracyclines, in that free oxygen radicals are formed that result in DNA breaks leading to cancer cell death. This drug is rarely used by itself rather in conjunction with other chemotherapies.

        Bleomycin is an active agent in regimens for testicular cancer and Hodgkin's lymphoma. The most concerning side effect of this drug is lung toxicities due to oxygen free radical formation.
        </H3>
        "The next major advancement in the health of American people will be determined by what the individual is willing to do for himself"-- John Knowles, Former President of the Rockefeller Foundation

        Comment


        • #5
          Re: Vitamin 'may blunt cancer drugs'

          Bad news.

          So an vitamin C therapy through food/tabs must be started only prior any cancer cell appearance.

          Instead healing, the help from vitamin C would be received by both, healthy, and illnessed tumoral cells which this way progress more.

          ___
          "A similar test was carried out on mice in which cancer cells were grafted. In the pretreated rodents by vitamin C, the tumours progressed more quickly.

          While seeking to include/understand the implied mechanisms, the researchers eliminated the antioxydant assumption, to turn to the mitochondries. The vitamin C protects them from the lesions due to the cancerous processes, which prevents the sending of a signal of apoptose by the injured mitochondries. The tumoral cells thus survive.

          The microenvironnement tumoral one, explain the authors, supports the transformation of vitamin C in its absorbable form by the cell, the DHA. Once included in the cell, the DHA is converted again into vitamin C which, sequestered in the cell, can protect it."

          Comment


          • #6
            Re: Vitamin 'may blunt cancer drugs'

            Vitamin C and specific informations.

            I have worked with a renowed oncologists whose formation came from the university in California tht initiated the Vitamine C treatment for cancer.

            The oncologist, now 75 yrs old had treated hundreds of patients, most of the time in terminal phase.

            As years went by, ( he was in relation with the lab of a renowed hospital in Montr?al and in weekly consultation with other oncologists and surgeons), a protocol was designed.

            Never, never take substantial amount of vitamin C 1 week prior to chemo treatment, this is a must, it altered results, it impose a major stress on the patient.

            On top of this some other elements in the IV must be introduce to reduce the bad effects of this overload of vita C.

            In 4 yrs of work with this oncologists here is what I have notice,

            Non terminal phase or advance phase of patients,
            Results are excellent, lab, pet scan and even surgery confirmed, BUT ALL THIS MUST BE DONE BY PROFESSIONNAL TEAM.

            As for more advenced invasion, I witness that the quality of Life was better (mainly due to the boost generated by vita C). and it was recognised that probably few months of life was allowed.

            These treatment are illegal because of protocol adopted by onclogists imposed by pharma clinical studies and approved by oncologists insurances.

            Just some honest wirnessing.

            Auto

            Comment


            • #7
              Re: Vitamin 'may blunt cancer drugs'

              Thank You very much autodidaktos (Sno.).

              Comment

              Working...
              X